| 1. Benchmarking leading countries' accreditation programs for ambulatory healthcare organizations. |
Page:1132—1143 |
| 2. Pharmacologic treatment of osteoarthritis. |
Page:1123—1131 |
| 3. The diagnosis and treatment of lymphedema. |
Page:1115—1122 |
| 4. Diagnosis and treatment of dementia in primary care. |
Page:1104—1112 |
| 5. Antivenom for snake bite in Korea. |
Page:1091—1103 |
| 6. Antidote for acquired methemoglobinemia: methylene blue. |
Page:1084—1090 |
| 7. Antidotes of cyanide intoxication. |
Page:1076—1083 |
| 8. Antidote for acetaminophen poisoning: N-acetylcysteine. |
Page:1067—1075 |
| 9. Antidote for organophosphate insecticide poisoning: atropine and pralidoxime. |
Page:1057—1066 |
| 10. Need for stocking of emergency antidotes. |
Page:1054—1056 |
| 11. The limitation of the current accreditation system for basic medical education in Republic of Korea. |
Page:1050—1052 |
| 12. An overview and considerations in prescribing H1-antihistamine. |
Page:231—239 |
| 13. Prevention and management of the diabetic foot. |
Page:220—228 |
| 14. Role of physician in reducing health inequity. |
Page:213—219 |
| 15. Current status of policy developments in tackling health inequalities and the next steps to be taken in Korea. |
Page:206—212 |
| 16. Global trends in health equity policy: lessons from experiences in the UK, the Netherlands, Sweden, and the World Health Organization. |
Page:195—205 |
| 17. Equity in health care: current situation in South Korea. |
Page:184—194 |
| 18. Socioeconomic inequalities in health risk factors in Korea. |
Page:175—183 |
| 19. Socioeconomic inequalities in health status in Korea. |
Page:167—174 |
| 20. One wing of nation's health: reducing health inequalities. |
Page:165—166 |
| 21. Can a medical regulatory system be implemented in Korea?. |
Page:158—163 |
| 22. Current status of healthcare and effective health aid strategies in North Korea. |
Page:368—374 |
| 23. Overview of healthcare system in North Korea. |
Page:358—367 |
| 24. The North Korean health and healthcare: issues and strategies. |
Page:356—357 |
| 25. The end of internship training in South Korea. |
Page:352—354 |
| 26. Inhalation medications in chronic airway disease. |
Page:625—631 |
| 27. Changing concepts of cancer stem cells and their application into targeted therapy for cancer. |
Page:611—624 |
| 28. Cardiopulmonary resuscitation update. |
Page:600—608 |
| 29. Anemia and nutrition in end stage renal disease patient. |
Page:592—599 |
| 30. The efficacy of dialysis adequacy. |
Page:583—591 |
| 31. Cardiovascular disease in end-stage renal disease. |
Page:576—582 |
| 32. Clinical outcomes by dialysis modality in patients with end stage renal disease. |
Page:569—575 |
| 33. Current status of dialysis therapy for ESRD patients in Korea. |
Page:562—568 |
| 34. Current status and future in patients with end stage renal disease in Korea. |
Page:560—561 |
| 35. The role of physicians in preventing school bullying. |
Page:554—558 |
| 36. Economic burden of otitis media and a survey of physicians for its practice and claim codes in Korea. |
Page:62—71 |
| 37. New oral anticoagulants. |
Page:57—61 |
| 38. Hair characteristics and androgenetic alopecia in Koreans. |
Page:45—54 |
| 39. Constraint-induced movement therapy. |
Page:38—44 |
| 40. Noninvasive brain stimulation: repetitive transcranial magnetic stimulation and transcranial direct current stimulation. |
Page:30—37 |
| 41. Robotics in rehabilitation for patients with brain disease. |
Page:23—29 |
| 42. Virtual reality based stroke rehabilitation. |
Page:16—22 |
| 43. Treatment of dysphagia in patients with brain disorders. |
Page:7—15 |
| 44. Current update of therapeutic interventions for stroke rehabilitation. |
Page:5—6 |
| 45. A new year's greeting message. |
Page:2—3 |
| 46. Biologic response modifiers. |
Page:135—141 |
| 47. Does our society have the proper understanding of death?. |
Page:129—134 |
| 48. Diagnosis and management of muscle pain. |
Page:120—126 |
| 49. National Evidence-based Collaborating Agency (NECA) Round-table Conference Consensus Statement: multidisciplinary responses to suicide, the first ranked cause of death in adolescents. |
Page:111—119 |
| 50. Current interventions, strategies, and networking of adolescent suicide. |
Page:100—110 |
| 51. Recent statistics and risk factors of suicide in children and adolescents. |
Page:93—99 |
| 52. Adolescent suicide in Korean society. |
Page:91—92 |
| 53. The establishment of medical terms in Korea. |
Page:86—89 |
| 54. Estimation of the prevalence of Korean adults aged 50 years or more with knee osteoarthritis based on the data from fifth Korea National Health and Nutrition Examination Survey. |
Page:431—436 |
| 55. Pharmacologic management of cardiac arrhythmias. |
Page:425—430 |
| 56. Sleep disorders medicine. |
Page:410—422 |
| 57. Recent advances in thrombolysis of acute ischemic stroke. |
Page:402—409 |
| 58. Plan on establishment of post-unification North Korean medical safety net. |
Page:394—401 |
| 59. The experiences of system integration countries informing the potential unification of the Korean peninsula's healthcare system. |
Page:389—393 |
| 60. The integration process of North Korean defector physicians into the South Korean medical system. |
Page:383—388 |
| 61. Current status and prospects of exchange of health officials from South and North Korea through non-governmental organizations. |
Page:375—382 |
| 62. Plasma volume expanders: classification and characteristics of colloids. |
Page:924—932 |
| 63. Nonoperative management of ankle arthritis. |
Page:917—923 |
| 64. Surgical treatments of the ankle arthritis. |
Page:908—914 |
| 65. Primary care research in South Korea: its importance and enhancing strategies for enhancement. |
Page:899—907 |
| 66. Reforming medical education for strengthening primary care. |
Page:891—898 |
| 67. Payment reform for the improvement of primary care in Korea. |
Page:881—890 |
| 68. Standard model and quality appraisal framework for the organization of primary care. |
Page:866—880 |
| 69. Concept, values, current status and prospect of primary care in Korea. |
Page:856—865 |
| 70. Strategies to strengthen primary care for the efficiency and equity of health care in Korea. |
Page:853—855 |
| 71. The hope and hype of stem cell therapy. |
Page:848—851 |
| 72. Necessity and the strategy to establish a national poison center in Korea: through needs survey analysis and database status for Chemical Accident Emergency Respond Information System. |
Page:724—735 |
| 73. Perspectives of clinical epidemiology in Korea. |
Page:718—723 |
| 74. Opioids use for chronic noncancer pain. |
Page:711—717 |
| 75. Multiple sclerosis. |
Page:702—708 |
| 76. Deep brain stimulation: mechanism, surgical procedure, and clinical applications. |
Page:695—701 |
| 77. Training residents in the prevention of legal disputes. |
Page:686—694 |
| 78. Recent trend of precedents for National Health Insurance. |
Page:676—685 |
| 79. Effect of Bioethics and Safety Act in medical research. |
Page:665—675 |
| 80. Criminal liability of medical professionals. |
Page:655—664 |
| 81. Civil liability for medical malpractice. |
Page:648—654 |
| 82. Medical law for physicians. |
Page:646—647 |
| 83. Concerns about non-anesthesiologists administration of intravenous anesthetics. |
Page:642—644 |
| 84. The determinants of official development assistance for healthcare in Korea. |
Page:827—836 |
| 85. Management of sepsis. |
Page:819—826 |
| 86. Surgical treatment of atrial fibrillation. |
Page:805—816 |
| 87. Contemporary medical understanding of the 'no-fault accident' during birth: amniotic fluid embolism, pulmonary embolism, meconium aspiration syndrome, and cerebral palsy. |
Page:784—804 |
| 88. Treating and preventing relapse of drug abuse by healthcare providers. |
Page:778—783 |
| 89. Propofol abuse among healthcare professionals. |
Page:771—777 |
| 90. Neurobiology, pharmacokinetics and pharmacodynamics of drug abuse. |
Page:762—770 |
| 91. Medical environment and drug abuse among physicians: current state and problems in Korea. |
Page:755—761 |
| 92. Healthcare providers have to be careful with drug abuse in Korea. |
Page:752—754 |
| 93. Optimal trauma care system in Korea. |
Page:748—750 |
| 94. Pharmacokinetics and pharmacodynamics of drugs for sedation. |
Page:279—284 |
| 95. Procedural sedation and analgesia in children. |
Page:271—278 |
| 96. The current state of sedation outside the operating room. |
Page:264—270 |
| 97. Procedural sedation. |
Page:262—263 |
| 98. Medical ethics and self-regulation in Korean medical society. |
Page:258—260 |
| 99. Clinical chemistry values in elderly Korean people: single institutional study. |
Page:533—540 |
| 100. Comparative study on medical fees: caesarean section, cataract, and appendectomy surgeries among OECD countries. |
Page:523—532 |
| 101. Chemotherapeutic drugs for common parasitic diseases in Korea. |
Page:513—522 |
| 102. Infant and toddler vision care: a supplement to the Manual of Infant Health Screening conducted by Korean National Health Insurance Corporation. |
Page:504—510 |
| 103. Recent review on blood transfusion therapy. |
Page:496—503 |
| 104. Measuring stress with questionnaires. |
Page:485—495 |
| 105. Evidence-based stress management: focusing on nonpharmacological procedure which reduce stress and promote health. |
Page:478—484 |
| 106. Stress and mental illness. |
Page:471—477 |
| 107. Stress and cardiovascular disease. |
Page:462—470 |
| 108. Stress and disease: evidence based review. |
Page:460—461 |
| 109. Management and perspectives of patient safety in healthcare. |
Page:454—458 |
| 110. A survey on the appropriate level of premiums for National Health Insurance. |
Page:326—335 |
| 111. Clinical use of oral contraceptives. |
Page:321—325 |
| 112. Recent advance on vitamin D. |
Page:310—318 |
| 113. Presbyopia and contact lenses. |
Page:303—309 |
| 114. Requirements and circumstances for safe sedation. |
Page:299—302 |
| 115. Drug abuse associated with procedural sedation. |
Page:292—298 |
| 116. Issues in procedural sedation outside the operating theater: characteristics and safety of commonly used sedatives and analgesics. |
Page:285—291 |
| 117. Ethical principles and practice guidelines concerning the usage of public database for medical researches. |
Page:1031—1038 |
| 118. Antitussive and mucoactive drugs. |
Page:1025—1030 |
| 119. Prevention and treatment of hallux valgus. |
Page:1017—1022 |
| 120. Periorbital changes with aging. |
Page:1012—1016 |
| 121. Management of viral hepatitis in patients with hepatocellular carcinoma. |
Page:1001—1011 |
| 122. Recent advances in systemic chemotherapy of hepatocellular carcinoma. |
Page:993—1000 |
| 123. Recent developments in radiotherapy for hepatocellular carcinoma. |
Page:983—992 |
| 124. Recent advance in international management of hepatocellular carcinoma. |
Page:972—982 |
| 125. Recent advance of local ablation for hepatocellular carcinoma. |
Page:964—971 |
| 126. Recent advances in hepatic resection and liver transplantation for hepatocellular carcinoma. |
Page:956—963 |
| 127. Recent development of diagnostic imaging of hepatocellular carcinoma. |
Page:948—955 |
| 128. Recent advances in the management of hepatocellular carcinoma. |
Page:946—947 |
| 129. 1 Years after beginning of DRG services system. |
Page:942—944 |
